Carisma Therapeutics Expands Leadership Team

January 6, 2020

PHILADELPHIA, Jan. 6, 2020 /PRNewswire/ —¬†Carisma Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced the expansion of its leadership team with Debora Barton, M.D., as Chief Medical Officer (CMO), and Tom Wilton, as Chief Business Officer (CBO). Both Dr. Barton and Wilton will play critical roles as Carisma continues to pioneer the development of engineered macrophages to transform the treatment of cancer and harness the power of innate and adaptive immunology.

Full press release can be found here.